Search results
Results from the WOW.Com Content Network
The key safe handling is to protect the health care worker throughout the three phases of contact with the hazardous drugs. These phases are drug preparation, administration and disposal. Some studies have shown that while compounding hazardous drugs in a Class II BSC in conjunction with a closed-system drug transfer device, a significant ...
For example, the CHOP regimen consists of cyclophosphamide, doxorubicin, vincristine and prednisone. Besides chemotherapy, medical oncology (pharmacotherapy for cancer) includes several noncytotoxic classes of therapy, such as hormonal therapy and targeted therapy (biologic therapy). Those agents are described in the relevant articles.
For example, the chemotherapeutic drugs oxaliplatin and ... Cyclophosphamide is a common cytotoxic drug used in this manner ... Safe Handling of Hazardous Drugs;
Examples of toxic agents are toxic metals, toxic chemicals, microbe neurotoxins, radiation particles and even specific neurotransmitters when the system is out of balance. Also some types of drugs, e.g alcohol , [ 1 ] and some venom , e.g. from the puff adder ( Bitis arietans ) or brown recluse spider ( Loxosceles reclusa ) are toxic to cells.
The safe handling of carcinogens is the handling of cancer causing substances in a safe and responsible manner. Carcinogens are defined as 'a substance or agent that can cause cells to become cancerous by altering their genetic structure so that they multiply continuously and become malignant '. [ 1 ]
A closed system drug transfer device or "CSTD" is a drug transfer device that mechanically prohibits the transfer of environmental contaminants into a system and the escape of hazardous drug or vapor concentrations outside the system. Open versus closed systems are commonly applied in medical devices to maintain the sterility of a fluid pathway.
1. Cytotoxic antineoplastics: 1.01 Nucleoside analogues: Azacitidine: SC, IV: DNA methyltransferase inhibitor and incorporates itself into RNA, hence inhibiting gene expression. [6] Myelodysplastic syndromes, acute myeloid leukaemia and chronic myeloid leukaemia: Myelosuppression, kidney failure (uncommon/rare), renal tubular acidosis and ...
USP 800 (Hazardous Drugs—Handling in Healthcare Settings) is a guideline created by the United States Pharmacopeia Convention (USP), as one of their General Chapters through which the USP "sets quality standards for medicines, dietary supplements and food ingredients".